BIOTON S.A. (WSE: BIO)
Poland
· Delayed Price · Currency is PLN
3.395
+0.050 (1.49%)
Sep 27, 2024, 5:00 PM CET
BIOTON Revenue
BIOTON had revenue of 50.61M PLN in the quarter ending June 30, 2024, with 3.20% growth. This brings the company's revenue in the last twelve months to 186.32M, down -14.72% year-over-year. In the year 2023, BIOTON had annual revenue of 181.64M, down -22.10%.
Revenue (ttm)
186.32M
Revenue Growth
-14.72%
P/S Ratio
1.56
Revenue / Employee
521.89K
Employees
357
Market Cap
291.51M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 181.64M | -51.52M | -22.10% |
Dec 31, 2022 | 233.16M | 70.13M | 43.01% |
Dec 31, 2021 | 163.03M | -58.75M | -26.49% |
Dec 31, 2020 | 221.79M | 19.76M | 9.78% |
Dec 31, 2019 | 202.03M | -39.13M | -16.23% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Krka, d. d. | 8.06B |
NEUCA S.A. | 12.13B |
Sopharma AD | 4.35B |
Synektik Spólka Akcyjna | 618.67M |
Celon Pharma S.A. | 206.81M |
Ryvu Therapeutics S.A. | 82.39M |
Voxel S.A. | 476.19M |
Selvita S.A. | 329.02M |